Search Results - Blumel, S.M.

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    COMBINATION OF TGR‐1202, UBLITUXIMAB, AND BENDAMUSTINE IS SAFE AND HIGHLY ACTIVE IN PATIENTS WITH ADVANCED DLBCL AND FOLLICULAR LYMPHOMA

    COMBINATION OF TGR‐1202, UBLITUXIMAB, AND BENDAMUSTINE IS SAFE AND HIGHLY ACTIVE IN PATIENTS WITH ADVANCED DLBCL AND FOLLICULAR LYMPHOMA by Lunning, M.A., Vose, J.M., Bierman, P.J., Bociek, G., Schreeder, M.T., Siddiqi, T., Blumel, S.M., Cutter, K., Pauli, E.K., Bui, D., Sportelli, P., Miskin, H.P., Purdom, M., Weiss, M.S., Fowler, N.H.

    Published in Hematological oncology
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Reducing Barriers: Migrations, Minor Ailments and Medicines

    Reducing Barriers: Migrations, Minor Ailments and Medicines by Gobetz, S.M., Heydon, S., Fink, C.C., Blümel, M., Kungl, A.

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: